These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 9039879)

  • 41. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
    Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
    AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of NMDA receptor-mediated excitatory postsynaptic currents by gp120-treated macrophages: implications for HIV-1-associated neuropathology.
    Yang J; Hu D; Xia J; Liu J; Zhang G; Gendelman HE; Boukli NM; Xiong H
    J Neuroimmune Pharmacol; 2013 Sep; 8(4):921-33. PubMed ID: 23660833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of HIV-1 Tat induced neurotoxicity in rat cortical cell culture.
    Pérez A; Probert AW; Wang KK; Sharmeen L
    J Neurovirol; 2001 Feb; 7(1):1-10. PubMed ID: 11519477
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The highly integrated dialogue between neurons and astrocytes in brain function.
    Vesce S; Bezzi P; Volterra A
    Sci Prog; 1999; 82 ( Pt 3)(3):251-70. PubMed ID: 10534972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated cerebrospinal fluid glutamate in patients with HIV-related dementia.
    Gurwitz D; Kloog Y
    JAMA; 1997 Jun; 277(24):1931. PubMed ID: 9200627
    [No Abstract]   [Full Text] [Related]  

  • 46. Glutamate may be the soluble cerebrospinal fluid factor that induces calcium dysregulation in cultured astrocytes in HIV dementia.
    Tremolizzo L; Aliprandi A; Longoni M; Stanzani L; Ferrarese C
    AIDS; 2002 Aug; 16(12):1691-2; author reply 1692-3. PubMed ID: 12172094
    [No Abstract]   [Full Text] [Related]  

  • 47. Relevance of glutamate levels in the CSF of patients with HIV-1-associated dementia complex.
    Espey MG; Ellis RJ; Heaton RK; Basile AS
    Neurology; 1999 Sep; 53(5):1144-5. PubMed ID: 10496286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased glutamate in CSF and plasma of patients with HIV dementia.
    Espey MG; Basile AS; Heaton RK; Ellis RJ
    Neurology; 2002 May; 58(9):1439; author reply 1439-40. PubMed ID: 12011305
    [No Abstract]   [Full Text] [Related]  

  • 49. Glutamate metabolism and HIV-associated neurocognitive disorders.
    Vázquez-Santiago FJ; Noel RJ; Porter JT; Rivera-Amill V
    J Neurovirol; 2014 Aug; 20(4):315-31. PubMed ID: 24867611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated glutamate in the cerebrospinal fluid of patients with HIV dementia.
    Ferrarese C; Riva R; Dolara A; De Micheli A; Frattola L
    JAMA; 1997 Feb; 277(8):630. PubMed ID: 9039879
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.